Login / Signup

PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through the miR-7-5p/Akt3/Wnt-β-catenin pathway.

Huanhuan ZhangFei DuDan LiJiayun ZhangWulin Shan
Published in: Translational cancer research (2024)
PA-MSHA controlled the miR-7-5p/Akt3/Wnt-β-catenin pathway to provide substantial efficacy against cetuximab-resistant CRC.
Keyphrases
  • cell proliferation
  • signaling pathway
  • stem cells
  • metastatic colorectal cancer
  • locally advanced
  • squamous cell carcinoma
  • anti inflammatory
  • radiation therapy
  • rectal cancer